Cassava Sciences Inc (SAVA)
25.75
-0.46
(-1.76%)
USD |
NASDAQ |
Nov 04, 13:04
Cassava Sciences Total Assets (Quarterly): 243.57M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 243.57M |
| March 31, 2024 | 155.72M |
| December 31, 2023 | 151.66M |
| September 30, 2023 | 172.53M |
| June 30, 2023 | 197.25M |
| March 31, 2023 | 218.11M |
| December 31, 2022 | 234.83M |
| September 30, 2022 | 207.29M |
| June 30, 2022 | 227.38M |
| March 31, 2022 | 244.19M |
| December 31, 2021 | 266.78M |
| September 30, 2021 | 274.25M |
| June 30, 2021 | 281.30M |
| March 31, 2021 | 284.05M |
| December 31, 2020 | 94.30M |
| September 30, 2020 | 25.40M |
| June 30, 2020 | 25.50M |
| March 31, 2020 | 25.98M |
| December 31, 2019 | 23.49M |
| September 30, 2019 | 18.38M |
| June 30, 2019 | 18.80M |
| March 31, 2019 | 19.52M |
| December 31, 2018 | 20.14M |
| September 30, 2018 | 20.84M |
| June 30, 2018 | 9.833M |
| Date | Value |
|---|---|
| March 31, 2018 | 11.06M |
| December 31, 2017 | 10.83M |
| September 30, 2017 | 12.38M |
| June 30, 2017 | 14.27M |
| March 31, 2017 | 17.60M |
| December 31, 2016 | 19.30M |
| September 30, 2016 | 22.48M |
| June 30, 2016 | 24.94M |
| March 31, 2016 | 28.63M |
| December 31, 2015 | 31.92M |
| September 30, 2015 | 35.65M |
| June 30, 2015 | 37.76M |
| March 31, 2015 | 39.64M |
| December 31, 2014 | 40.91M |
| September 30, 2014 | 43.59M |
| June 30, 2014 | 45.39M |
| March 31, 2014 | 47.32M |
| December 31, 2013 | 50.10M |
| September 30, 2013 | 51.76M |
| June 30, 2013 | 53.20M |
| March 31, 2013 | 54.87M |
| December 31, 2012 | 56.86M |
| September 30, 2012 | 93.26M |
| June 30, 2012 | 94.44M |
| March 31, 2012 | 96.81M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
23.49M
Minimum
Dec 2019
284.05M
Maximum
Mar 2021
176.50M
Average
207.29M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 93.67B |
| Eli Lilly and Co | 75.61B |
| Seelos Therapeutics Inc | 2.381M |
| Biomarin Pharmaceutical Inc | 6.851B |
| EyePoint Pharmaceuticals Inc | 324.25M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 54.59M |
| Shareholders Equity (Quarterly) | 188.97M |